DK587085A - Homonojirimycin-glycosider og deres fremstilling - Google Patents

Homonojirimycin-glycosider og deres fremstilling Download PDF

Info

Publication number
DK587085A
DK587085A DK587085A DK587085A DK587085A DK 587085 A DK587085 A DK 587085A DK 587085 A DK587085 A DK 587085A DK 587085 A DK587085 A DK 587085A DK 587085 A DK587085 A DK 587085A
Authority
DK
Denmark
Prior art keywords
homonojirimycin
preparation
glycosides
homonojirimycin glycosides
protected
Prior art date
Application number
DK587085A
Other languages
English (en)
Other versions
DK587085D0 (da
Inventor
Paul S Liu
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK587085D0 publication Critical patent/DK587085D0/da
Publication of DK587085A publication Critical patent/DK587085A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)
DK587085A 1984-12-18 1985-12-17 Homonojirimycin-glycosider og deres fremstilling DK587085A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/683,127 US4634765A (en) 1984-12-18 1984-12-18 Homodisaccharide hypoglycemic agents

Publications (2)

Publication Number Publication Date
DK587085D0 DK587085D0 (da) 1985-12-17
DK587085A true DK587085A (da) 1986-06-19

Family

ID=24742682

Family Applications (1)

Application Number Title Priority Date Filing Date
DK587085A DK587085A (da) 1984-12-18 1985-12-17 Homonojirimycin-glycosider og deres fremstilling

Country Status (20)

Country Link
US (1) US4634765A (da)
EP (1) EP0186103B1 (da)
JP (1) JPS61158994A (da)
KR (1) KR900005607B1 (da)
CN (1) CN1016784B (da)
AT (1) ATE62249T1 (da)
AU (1) AU574246B2 (da)
CA (1) CA1240989A (da)
DE (1) DE3582420D1 (da)
DK (1) DK587085A (da)
ES (1) ES8706164A1 (da)
FI (1) FI80707C (da)
GR (1) GR853032B (da)
HU (1) HU194263B (da)
IE (1) IE58186B1 (da)
NO (1) NO162387B (da)
NZ (1) NZ214570A (da)
PH (1) PH23660A (da)
PT (1) PT81689B (da)
ZA (1) ZA859573B (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2181729B (en) * 1985-10-12 1990-04-04 Nippon Shinyaku Co Ltd Glucosylmoranoline derivatives and production thereof
JPS62242692A (ja) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd モラノリン誘導体の製造法
EP0344383A1 (en) * 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Novel alpha-Glucosidase inhibitors
EP0345104B1 (en) * 1988-06-02 1995-11-02 Merrell Dow Pharmaceuticals Inc. Novel Alpha-glucosidase inhibitors
US4880917A (en) * 1988-07-01 1989-11-14 Merrell Dow Pharmaceuticals Inc. Process for hydrolyzing 2,6-dideoxy-2,6-iminoheptononitrile derivatives using trifluoroacetic acid and dinitrogen tetroxide
US4908439A (en) * 1988-09-16 1990-03-13 Merrell Dow Pharmaceuticals Inc. Synthesis of intermediate useful in the preparation of nojirimycin and related compounds
US5227479A (en) * 1989-12-20 1993-07-13 Merrell Dow Pharmaceuticals Inc. Process for the preparation of nojirimycin and related compounds
US5504078A (en) * 1990-06-08 1996-04-02 Merrell Dow Pharmaceuticals Inc. α-glucosidase inhibitors
CA2283564C (en) * 1997-04-15 2007-07-10 Csir Pharmaceutical compositions having appetite suppressant activity
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
CA2362836C (en) 2000-03-31 2006-12-19 Michigan State University Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
CN101228174A (zh) * 2005-06-08 2008-07-23 阿米库斯治疗学公司 晶体糖组合物及其制备方法
EP1888610A1 (en) * 2005-06-08 2008-02-20 Amicus Therapeutics, Inc. Stabilization of triflated compounds
DK2027137T3 (da) * 2005-06-08 2015-05-18 Amicus Therapeutics Inc Imino- og aminosukkeroprensning
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8877717B2 (en) 2007-03-12 2014-11-04 Zadec Aps Anti-diabetic extract of rooibos
JP5546451B2 (ja) 2007-06-04 2014-07-09 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2571860A1 (en) 2010-05-21 2013-03-27 Pfizer Inc 2-phenyl benzoylamides
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN102462726B (zh) * 2010-11-04 2016-03-09 中国医学科学院药物研究所 白树总生物碱及多羟基生物碱化合物的提取、分离及用途
EP2680874A2 (en) 2011-03-04 2014-01-08 Pfizer Inc Edn3-like peptides and uses thereof
WO2012155916A1 (en) * 2011-05-13 2012-11-22 Glycom A/S Manufacture of lacto-n-tetraose
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
AU2015308350B2 (en) 2014-08-29 2020-03-05 Tes Pharma S.R.L. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104530150A (zh) * 2015-01-14 2015-04-22 佛山市赛维斯医药科技有限公司 含胺基苯和双葡萄糖苷结构化合物、其制备方法和用途
MX2019004321A (es) 2016-10-14 2019-06-12 Tes Pharma S R L Inhibidores de la acido alfa-amino-beta-carboximuconico semialdehido descarboxilasa.
IT201700078102A1 (it) 2017-07-11 2019-01-11 Dipharma Francis Srl Sintesi di un azazucchero e suoi intermedi
CN108828121B (zh) * 2018-06-14 2020-06-05 华润三九医药股份有限公司 一种白树药材中α-高野尻霉素的含量检测方法
JP2022507805A (ja) 2018-11-20 2022-01-18 ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ α－アミノ－β－カルボキシムコン酸セミアルデヒドデカルボキシラーゼ阻害剤
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2848117A1 (de) * 1978-11-06 1980-05-14 Bayer Ag Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels
DE2942365A1 (de) * 1979-10-19 1981-05-14 Bayer Ag, 5090 Leverkusen 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB2064527B (en) * 1979-12-08 1984-05-02 Nippon Shinyaku Co Ltd Moranoline derivatives and process for preparation thereof
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.

Also Published As

Publication number Publication date
ES550060A0 (es) 1987-06-01
HUT40137A (en) 1986-11-28
JPS61158994A (ja) 1986-07-18
EP0186103A3 (en) 1988-02-03
CN1016784B (zh) 1992-05-27
AU574246B2 (en) 1988-06-30
CN85109548A (zh) 1986-07-09
NO162387B (no) 1989-09-11
CA1240989A (en) 1988-08-23
EP0186103B1 (en) 1991-04-03
PH23660A (en) 1989-09-27
DK587085D0 (da) 1985-12-17
FI854944A (fi) 1986-06-19
FI80707B (fi) 1990-03-30
HU194263B (en) 1988-01-28
KR900005607B1 (ko) 1990-07-31
ES8706164A1 (es) 1987-06-01
JPH0565519B2 (da) 1993-09-17
GR853032B (da) 1986-04-18
NO855087L (no) 1986-06-19
PT81689B (pt) 1987-11-30
US4634765A (en) 1987-01-06
DE3582420D1 (de) 1991-05-08
FI854944A0 (fi) 1985-12-13
ZA859573B (en) 1986-08-27
KR860004921A (ko) 1986-07-16
IE58186B1 (en) 1993-07-28
ATE62249T1 (de) 1991-04-15
AU5081085A (en) 1986-06-26
FI80707C (fi) 1990-07-10
IE853179L (en) 1986-06-18
EP0186103A2 (en) 1986-07-02
NZ214570A (en) 1988-03-30
PT81689A (en) 1986-01-01

Similar Documents

Publication Publication Date Title
DK587085D0 (da) Homonojirimycin-glycosider og deres fremstilling
IT8424165A0 (it) Elemento di imbottitura protettiva paracolpi.
IT8847884A0 (it) Elettrodo enzimatico e modulo di elettrodo nonche' relativo metodo di impiego
IT8821542A0 (it) Composti attivi come inibitori della biosintesi del colesterolo.
DK149776C (da) Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
DK438788A (da) Alkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende dem
DE3485210D1 (de) Immobilisierte enzymzusammensetzungen.
NO885640D0 (no) Framgangsmaate og sammensetninger for katodisk beskyttelse.
IT8520090A0 (it) Procedimento di purificazione di un enzima.
IT8519862A0 (it) Composizione di policarbonato autoestinguente.
AU4994585A (en) Pesticidal biphenylyloxy and biphenylylalkoxy aryl acyl urea compounds
DE3577656D1 (de) Pharmazeutische zusammensetzungen von ceftazidim.
IT8422516A0 (it) Composizione di policarbonato autoestinguente.
IT8422517A0 (it) Composizione di policarbonato autoestinguente.
IT8320426A0 (it) Composizione di policarbonato autoestinguente.
IT8320903A0 (it) Composizione di policarbonato autoestinguente.
FI915516A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva 2-pyridylalkensulfinyl) benzimidazoler.
IL72703A (en) Derivatives of alpha-allenic-alpha-amino acids and 2-allenylpyrrolidine-2-carboxylic acids,their preparation and pharmaceutical compositions containing them
AU8315687A (en) Propagation of seedlings
BR8702253A (pt) Protecao contra escrita em disquetes
IT8221699A0 (it) Composizione di policarbonato autoestinguente.
IT8222987A0 (it) Composizione di policarbonato autoestinguente.
IT8222968A0 (it) Composizione di policarbonato autoestinguente.
IT8222965A0 (it) Composizione di policarbonato autoestinguente.
IT8222964A0 (it) Composizione di policarbonato autoestinguente.

Legal Events

Date Code Title Description
ATS Application withdrawn